Skip to main content

Opportunities and Approaches for Supplying Molybdenum-99 and Associated Medical Isotopes to Global Markets: A Symposium

Completed

Participants of the July 17-18, 2017, symposium titled Opportunities and Approaches for Supplying Molybdenum-99 and Associated Medical Isotopes to Global Markets examined current trends in molybdenum-99 production, prospects for new global supplies, and technical, economic, regulatory, and other considerations for supplying molybdenum-99 to global markets.

Description

The U.S. National Academies of Sciences, Engineering, and Medicine (the National Academies) and the Russian Academy of Sciences will organize a joint symposium to discuss opportunities and approaches for supplying molybdenum-99 (Mo-99) and associated medical isotopes (iodine-131 and xenon-133) to global markets. The symposium will address the following topics:

  • Trends in global demand and supply for Mo-99 and associated medical isotopes.
  • Prospects and approaches for developing new global supplies of Mo-99 and associated medical isotopes.
  • Technical, regulatory, economic, and policy considerations for producing Mo-99 and associated medical isotopes for global markets using uranium-fission and other processes.

The symposium presentations and discussions will be summarized in a National Academies proceedings that will be issued in English and Russian.

Contributors

Committee

Chair

Member

Member

Sponsors

Department of Energy

Staff

Ourania Kosti

Lead

Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.